A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids With Mycophenolate Mofetil vs. Corticosteroids With Placebo as Initial Systemic Treatment of Acute Graft-Vs-Host-Disease (BMT CTN #0802)
收藏DataCite Commons2026-02-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003271/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is a Phase III, randomized double blind, placebo controlled, and trial evaluating the addition of Mycophenolate mofetil (MMF) vs. placebo to systemic corticosteroids as initial therapy for acute Graft Vs Host Disease (GVHD). The primary endpoint will be GVHD free survival at Day 56 post randomization.
提供机构：
Vivli
创建时间：
2018-11-13
